---
title: Celerion vs Sword Bio
slug_a: celerion
slug_b: swordbio
site: cro
review_signal_gate: closed
canonical_path: /compare/celerion/swordbio
---

# Celerion vs Sword Bio

Side-by-side profile data from each company listing on this directory.

## Celerion

- Profile: [/companies/celerion](/companies/celerion)

Celerion — Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.

Services: 15. Modalities: 5. Indications: 4. Locations: 9. Certifications: 0. The strongest documented coverage currently appears in services (15).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Clinical Imaging Core Lab
- Regulatory Affairs

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Gene Therapy

### Indications

- Immunology
- Metabolic
- Cardiovascular
- Respiratory

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Preclinical (General)

### Sourcing models

- Full-Service Outsourcing (FSO)

## Sword Bio

- Profile: [/companies/swordbio](/companies/swordbio)

Sword Bio — Bioanalytical CRO offering ligand binding assay development, PK, immunogenicity (ADA and NAb), and custom biomarker assays under non-GLP, spirit-of-GLP, and GLP conditions. Supports clients from discovery through clinical Phase IV.

Services: 5. Modalities: 4. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Bioanalysis
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Analytical Method Development & Validation

### Modalities

- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
- Gene Therapy

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Data not yet provided.